104 related articles for article (PubMed ID: 27021541)
1. Comparison of MMP2 and MMP9 expression levels between primary and metastatic regions of oral squamous cell carcinoma.
Nishio K; Motozawa K; Omagari D; Gojoubori T; Ikeda T; Asano M; Gionhaku N
J Oral Sci; 2016; 58(1):59-65. PubMed ID: 27021541
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
[TBL] [Abstract][Full Text] [Related]
3. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential.
Hong SD; Hong SP; Lee JI; Lim CY
Oral Oncol; 2000 Mar; 36(2):207-13. PubMed ID: 10745174
[TBL] [Abstract][Full Text] [Related]
6. MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.
Ahmed Haji Omar A; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Salo T; Sorsa T; Hagström J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Apr; 119(4):459-67. PubMed ID: 25697929
[TBL] [Abstract][Full Text] [Related]
7. Relationship between matrix metalloproteinase 2 and lung cancer progression.
Guo CB; Wang S; Deng C; Zhang DL; Wang FL; Jin XQ
Mol Diagn Ther; 2007; 11(3):183-92. PubMed ID: 17570740
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.
Yorioka CW; Coletta RD; Alves F; Nishimoto IN; Kowalski LP; Graner E
Int J Oncol; 2002 Jan; 20(1):189-94. PubMed ID: 11743663
[TBL] [Abstract][Full Text] [Related]
9. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.
Ogbureke KU; Nikitakis NG; Warburton G; Ord RA; Sauk JJ; Waller JL; Fisher LW
Oral Oncol; 2007 Oct; 43(9):920-32. PubMed ID: 17306612
[TBL] [Abstract][Full Text] [Related]
12. Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in primary oral squamous cell carcinoma and corresponding metastases in cervical lymph nodes: association with the metastasis suppressor CD82.
Kawasaki G; Yoshitomi I; Yanamoto S; Yamada S; Mizuno A; Umeda M
Anticancer Res; 2011 Oct; 31(10):3521-6. PubMed ID: 21965773
[TBL] [Abstract][Full Text] [Related]
13. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
[TBL] [Abstract][Full Text] [Related]
14. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
Bindhu OS; Ramadas K; Sebastian P; Pillai MR
Head Neck; 2006 Oct; 28(10):916-25. PubMed ID: 16823875
[TBL] [Abstract][Full Text] [Related]
15. Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma--in vitro and in vivo studies.
Shen LC; Chen YK; Lin LM; Shaw SY
Oral Oncol; 2010 Mar; 46(3):178-84. PubMed ID: 20036604
[TBL] [Abstract][Full Text] [Related]
16. [The correlation between neck lymphy node metastasis and matrixmetalloproteinase-2 expression at the invasive tumor front of oral squamous cell carcinomas].
Liu LK; Li YN; Jiang HB; He ZX; Yi XZ
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):106-8. PubMed ID: 15190788
[TBL] [Abstract][Full Text] [Related]
17. Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis.
Kawamata H; Uchida D; Hamano H; Kimura-Yanagawa T; Nakashiro KI; Hino S; Omotehara F; Yoshida H; Sato M
Int J Oncol; 1998 Oct; 13(4):699-704. PubMed ID: 9735398
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of MMP-2, MMP-9 and CD31/microvascular density in squamous cell carcinomas of the floor of the mouth.
Monteiro-Amado F; Castro-Silva II; Lima CJ; Soares FA; Kowalski LP; Granjeiro JM
Braz Dent J; 2013; 24(1):3-9. PubMed ID: 23657405
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of beta-dystroglycan may be due to processing by matrix metalloproteinases-2 and -9 in oral squamous cell carcinoma.
Shang ZJ; Ethunandan M; Górecki DC; Brennan PA
Oral Oncol; 2008 Dec; 44(12):1139-46. PubMed ID: 18487074
[TBL] [Abstract][Full Text] [Related]
20. The effect of hypoxic microenvironment on matrix metalloproteinase expression in xenografts of human oral squamous cell carcinoma.
Miyazaki Y; Hara A; Kato K; Oyama T; Yamada Y; Mori H; Shibata T
Int J Oncol; 2008 Jan; 32(1):145-51. PubMed ID: 18097553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
